Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Lee

Showing results (281-290 of 365) with videos related to

Pageof 37
Sort By:
Journal of Psychiatric Research|June 10, 2014
Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of responseBrian P Brennan, Catherine Lee, Jason A Elias, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2011
Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitisJill M Scott, Christopher Baccei, Gretchen Bain, et al.
Antimicrobial Agents and Chemotherapy|January 5, 2011
Selective advantage of resistant strains at trace levels of antibiotics: a simple and ultrasensitive color test for detection of antibiotics and genotoxic agentsAnne Liu, Amie Fong, Elinne Becket, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2010
5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)-A potent FLAP inhibitor suitable for topical administrationNicholas Stock, Christopher Baccei, Gretchen Bain, et al.
The Oncologist|October 22, 2011
The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialistsJennifer E Joh, Nicole N Esposito, John V Kiluk, et al.
Global Mental Health (Cambridge, England)|March 4, 2026
A suicide safety protocol with vulnerable populations with chronic physical health conditions: A pragmatic protocol implementation among displaced Myanmar adults in ThailandSrishti Meera Sardana, Ye Htut Oo, Khin Nyein Chan Soe, et al.
JACC. Advances|July 22, 2025
The Association of Aortic Stenosis Severity and Symptom Status With Morbidity and MortalityMatthew D Solomon, Alan S Go, Thomas Leong, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2018
Discovery of potent and selective PPARα/δ dual antagonists and initial biological studiesJason D Jacintho, Christopher S Baccei, Yalda Bravo, et al.
Annals of Surgical Oncology|September 12, 2008
Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrenceKandice E Kilbride, M Catherine Lee, Alexis V Nees, et al.
Diabetes|November 21, 2024
The IsletTester Mouse: An Immunodeficient Model With Stable Hyperglycemia for the Study of Human IsletsEric L Waite, Mark Tigue, Ming Yu, et al.
Pageof 37

Showing results (281-290 of 365) with videos related to

Sort By:
Pageof 37
Journal of Psychiatric Research|June 10, 2014
Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of responseBrian P Brennan, Catherine Lee, Jason A Elias, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2011
Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitisJill M Scott, Christopher Baccei, Gretchen Bain, et al.
Antimicrobial Agents and Chemotherapy|January 5, 2011
Selective advantage of resistant strains at trace levels of antibiotics: a simple and ultrasensitive color test for detection of antibiotics and genotoxic agentsAnne Liu, Amie Fong, Elinne Becket, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2010
5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)-A potent FLAP inhibitor suitable for topical administrationNicholas Stock, Christopher Baccei, Gretchen Bain, et al.
The Oncologist|October 22, 2011
The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialistsJennifer E Joh, Nicole N Esposito, John V Kiluk, et al.
Global Mental Health (Cambridge, England)|March 4, 2026
A suicide safety protocol with vulnerable populations with chronic physical health conditions: A pragmatic protocol implementation among displaced Myanmar adults in ThailandSrishti Meera Sardana, Ye Htut Oo, Khin Nyein Chan Soe, et al.
JACC. Advances|July 22, 2025
The Association of Aortic Stenosis Severity and Symptom Status With Morbidity and MortalityMatthew D Solomon, Alan S Go, Thomas Leong, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2018
Discovery of potent and selective PPARα/δ dual antagonists and initial biological studiesJason D Jacintho, Christopher S Baccei, Yalda Bravo, et al.
Annals of Surgical Oncology|September 12, 2008
Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrenceKandice E Kilbride, M Catherine Lee, Alexis V Nees, et al.
Diabetes|November 21, 2024
The IsletTester Mouse: An Immunodeficient Model With Stable Hyperglycemia for the Study of Human IsletsEric L Waite, Mark Tigue, Ming Yu, et al.
Pageof 37